Toscana Life Sciences Sviluppo s.r.l.
2 clinical trials · Sponsor
◉ Watch Toscana Life Sciences Sviluppo s.r.l.
| Record | Firm | Date |
|---|---|---|
| Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19. (NCT04952805) | Toscana Life Sciences Sviluppo s.r.l. | 2021-06-06 |
| Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease. (NCT04932850) | Toscana Life Sciences Sviluppo s.r.l. | 2021-03-01 |
Track Toscana Life Sciences Sviluppo s.r.l. automatically
Every clearance here is in the API, with alerts when new ones post.